(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.96%) $81.14
(-2.26%) $1.946
(-0.20%) $2 298.20
(-0.28%) $26.58
(-0.50%) $943.50
(0.09%) $0.938
(0.24%) $11.12
(0.07%) $0.801
(0.00%) $93.45
@ $4.83
发出时间: 13 Feb 2024 @ 22:36
回报率: -23.60%
上一信号: Feb 7 - 02:59
上一信号:
回报率: 10.02 %
Live Chart Being Loaded With Signals
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States...
Stats | |
---|---|
今日成交量 | 98 294.00 |
平均成交量 | 163 535 |
市值 | 73.55M |
EPS | $0 ( 2024-03-21 ) |
下一个收益日期 | ( $-0.260 ) 2024-05-27 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -17.57 |
ATR14 | $0.0330 (0.91%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Rosenwald Lindsay A Md | Buy | 10 000 | Common Stock, $0.0001 par value |
2024-03-22 | Maraoui Claude | Buy | 10 000 | Common Stock, $0.0001 par value |
2024-03-22 | Smith Justin Adam | Buy | 30 000 | Common Stock, $0.0001 par value |
2024-03-22 | Rosenwald Lindsay A Md | Buy | 20 000 | Common Stock, $0.0001 par value |
2024-02-22 | Benesch Joseph | Sell | 2 450 | Common Stock, $0.0001 par value |
INSIDER POWER |
---|
75.70 |
Last 94 transactions |
Buy: 1 155 250 | Sell: 1 927 470 |
音量 相关性
Dermira Inc. 相关性 - 货币/商品
Dermira Inc. 财务报表
Annual | 2023 |
营收: | $79.18M |
毛利润: | $52.52M (66.33 %) |
EPS: | $-0.210 |
FY | 2023 |
营收: | $79.18M |
毛利润: | $52.52M (66.33 %) |
EPS: | $-0.210 |
FY | 2022 |
营收: | $73.67M |
毛利润: | $42.89M (58.23 %) |
EPS: | $-1.690 |
FY | 2021 |
营收: | $63.13M |
毛利润: | $31.05M (49.18 %) |
EPS: | $-2.68 |
Financial Reports:
No articles found.
Dermira Inc.
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。